TCMD

Tactile Systems Technology Inc Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$23.04Close $517.0MMarket cap $15.07 – $33.0552-week range Nov 2, 2026Next report · after the close

Highlights

Strengths

  • Earnings growing EPS +144% year on year

Cautions

  • Not in an uptrend 2 of 8 trend conditions
  • Lagging the market RS 38 · weaker than 62% of stocks over 12 months
  • Far from its high 30% below its 52-week high
  • Results soon Nov 2, 2026, in 1 day

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 10, 2026
Off 12-month high 30%
1wk down 2.5% price change
1mo up 3.4% price change
12-month return up 53% market up 11% · its own up 41%
F-score 8 / 9 Exceptional
Altman Z 8.02 Low risk
P/E 27.1× price / earnings
PEG 1.63 P/E / EPS growth
P/B 2.4× price / book
Earnings yield up 6.8% EBIT / enterprise value
Cheaper than 76% of the market · cheap
Revenue growth up 12% year on year
EPS growth up 144% latest quarter
Sales growth up 9% latest quarter · -14 pts
ROE up 9% return on equity
Free cash margin up 12% $40.4M FCF
D/E 0.00 long-term debt / equity
Net debt / EBITDA -2.3× net cash
Interest cover —EBIT / interest
Piotroski tests
  • short-term liquidity weakened
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • no new shares issued
  • gross margin widened
  • assets working harder

Repair signals

  • Long-term debt down 100% ($0.0B → $0.0B)
  • Gross margin 74.0% → 75.9%

Trade setup

ATR% 3.1% $0.71 a day · 2×ATR $21.63
RS 38 / 99 vs the universe
Trend 2 / 8 trend template
Relative volume 0.9× vs 50-day average
Up/down volume 1.05 50 sessions
Implied move — no option chain · report Nov 2, 2026
Trend template · 2 of 8
  • Price above the 50-day average: passes
  • At least 30% above the 52-week low: passes

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 10, 2026
Last shock Aug 11, 2026-17% in one session5.5× volumeon results-5% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $329.5M +12% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $187.1M FY2021 · $208.1M FY2022 · $246.8M FY2023 · $274.4M FY2024 · $293.0M FY2025 · $329.5M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $19.1M +13% on FY2024
-$20M $0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$620,000 FY2021 · -$11.8M FY2022 · -$17.9M FY2023 · $28.5M FY2024 · $17.0M FY2025 · $19.1M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $40.4M +6% on FY2024
$0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $735,000 FY2021 · $528,000 FY2022 · $3.4M FY2023 · $33.5M FY2024 · $38.3M FY2025 · $40.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 76%
  • Net 6%
  • Free cash 12%
0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 71% · Net -0% · Free cash 0% FY2021 · Gross 71% · Net -6% · Free cash 0% FY2022 · Gross 71% · Net -7% · Free cash 1% FY2023 · Gross 71% · Net 10% · Free cash 12% FY2024 · Gross 74% · Net 6% · Free cash 13% FY2025 · Gross 76% · Net 6% · Free cash 12%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $83.4M net cash
  • Cash
  • Long-term debt
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $47.9M FY2021 · Cash $28.2M · Long-term debt $26.9M FY2022 · Cash $21.9M · Long-term debt $21.0M FY2023 · Cash $61.0M · Long-term debt $16.8M FY2024 · Cash $94.4M · Long-term debt $23.2M FY2025 · Cash $83.4M · Long-term debt $0
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 22.44m +15.1% since FY2020
23.88m 19.49m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 19.49m FY2021 · 19.88m FY2022 · 20.25m FY2023 · 23.60m FY2024 · 23.88m FY2025 · 22.44m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $187.1M $208.1M $246.8M $274.4M $293.0M $329.5M
Gross margin 71% 71% 71% 71% 74% 76%
Operating income -$3.6M -$1.8M -$12.8M $18.0M $22.2M $29.3M
Net income -$620,000 -$11.8M -$17.9M $28.5M $17.0M $19.1M
Net margin -0% -6% -7% 10% 6% 6%
Earnings per share -$0.03 -$0.60 -$0.89 $1.23 $0.70 $0.82
Free cash flow $735,000 $528,000 $3.4M $33.5M $38.3M $40.4M
Free cash margin 0% 0% 1% 12% 13% 12%
Cash $47.9M $28.2M $21.9M $61.0M $94.4M $83.4M
Long-term debt — $26.9M $21.0M $16.8M $23.2M $0
Shareholders' equity $124.8M $128.2M $121.4M $193.6M $216.6M $218.9M
Shares outstanding 19.49m 19.88m 20.25m 23.60m 23.88m 22.44m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 10, 2026 Quarterly ↗ Jun 30, 2026 41d
May 4, 2026 Quarterly ↗ Mar 31, 2026 34d
Feb 17, 2026 Annual ↗ Dec 31, 2025 48d
Nov 3, 2025 Quarterly ↗ Sep 30, 2025 34d
Aug 4, 2025 Quarterly ↗ Jun 30, 2025 35d
May 5, 2025 Quarterly ↗ Mar 31, 2025 35d
Feb 18, 2025 Annual ↗ Dec 31, 2024 49d
Nov 4, 2024 Quarterly ↗ Sep 30, 2024 35d
Aug 5, 2024 Quarterly ↗ Jun 30, 2024 36d
May 6, 2024 Quarterly ↗ Mar 31, 2024 36d
Feb 20, 2024 Annual ↗ Dec 31, 2023 51d
Nov 6, 2023 Quarterly ↗ Sep 30, 2023 37d

Current reports